FDA appropriations bill passes House
This article was originally published in The Tan Sheet
Executive Summary
The House on Aug. 2 passed its appropriations bill, H.R. 3161, that includes FDA funding, which proposes $1.69 bil. in direct funding for the agency. No significant changes affecting FDA were made from the bill sent top the floor by the Agriculture Appropriations Subcommittee (1"The Tan Sheet" July 23, 2007, p. 4). The same day, Sen. Mike Enzi, R-Wyo., asked Majority Leader Harry Reid, D-Nev., to delay naming conferees for the legislation. "If we do this too early, we set ourselves up for the blame game, not for getting this key legislation done," Enzi said. The Senate has not yet passed its corresponding bill, S. 1859...
You may also be interested in...
Appropriators Boost FDA Budget For Food Safety While Opposing Lab Closings
House and Senate appropriators make it known in reports on FDA's fiscal 2008 appropriation that they question the agency's plan to close more than half of its field labs, with the House bill specifically banning funding for the reorganization
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.